TECNOLOGÍA PARA LA MONITORIZACIÓN Y CONTROL DE LA DIABETES

VolverVolver

Resultados 105 resultados LastUpdate Última actualización 19/09/2020 [18:05:00] pdf PDF xls XLS

Solicitudes publicadas en los últimos 60 días / Applications published in the last 60 days



Página1 de 5 nextPage   por página


SIMULTANEOUS BLOOD GLUCOSE MONITORING AND GASTRIC EMPTYING SCINTIGRAPHY

NºPublicación: WO2020185857A1 17/09/2020

Solicitante:

UNIV TEXAS [US]

Resumen de: WO2020185857A1

Systems and methods are provided for providing improved information, diagnoses and therapies for dyspepsia and gastric emptying disorders based on gastric protein emptying and gastric carbohydrate emptying data.

traducir

METHODS OF TREATING ACUTE CORONARY SYNDROMES

NºPublicación: WO2020185996A1 17/09/2020

Solicitante:

TUFTS MEDICAL CT INC [US]

Resumen de: WO2020185996A1

The invention provides methods for treating and preventing acute coronary syndromes (ACS). The methods involve initiation of the administration of glucose-insulin-potassium (GIK) soon (e.g., within 3 hours) after the onset of ACS symptoms.

traducir

NEUROMODULATION TO TARGET GLUCOSE TRANSPORTER AND/OR INCRETIN PATHWAYS

NºPublicación: WO2020186073A1 17/09/2020

Solicitante:

GEN ELECTRIC [US]

Resumen de: WO2020186073A1

The subject matter of the present disclosure generally relates to techniques for neuromodulation that include applying energy (e.g., ultrasound energy) into the tissue to cause a change in a glucose transporter pathway molecule and/or an incretin pathway molecule. In one embodiment, the neuromodulation is performed as a treatment of a metabolic disorder.

traducir

A NON-INVASIVE GLUCOMETER

NºPublicación: WO2020183497A1 17/09/2020

Solicitante:

BIOFI MEDICAL HEALTHCARE INDIA PRIVATE LTD [IN]

Resumen de: WO2020183497A1

A glucometer for monitoring blood glucose comprises a curved test surface with a transparent test site. The curved test surface accommodates a finger-tip and an enclosing lid encloses the finger-tip when it is placed on the transparent test site. The glucometer further comprises a light source assembly comprising light emitting diodes, underneath the transparent test site. The glucometer further comprises detectors for detecting transflective light, transmissive light, and reflective light from blood capillaries at a depth of 100 micro meters below skin surface. The glucometer further comprises a software module comprising a first sub-module that comprises a first set of algorithms for generating a data matrix. The transflective, transmissive light, and reflective light from blood capillaries are measured and recorded in data matrix. A second sub-module comprises a second set of algorithms for non-invasive measurement of concentration of glucose in the blood by processing data within the data matrix.

traducir

METHOD AND/OR SYSTEM FOR ASSESSING A PATIENT'S GLYCEMIC RESPONSE

NºPublicación: US2020289037A1 17/09/2020

Solicitante:

MEDTRONIC MINIMED INC [US]

US_2013190583_PA

Resumen de: US2020289037A1

Subject matter disclosed herein relates to a method and/or system for tailoring insulin therapies to physiological characteristics of a patient. In particular, observations of a blood glucose concentration of a patient responsive to a meal profile and an insulin profile may be used for estimating one or more physiological parameters.

traducir

NEAR-INFRARED SPECTROSCOPY (NIR) BASED GLUCOSE PREDICTION USING DEEP LEARNING

NºPublicación: US2020293882A1 17/09/2020

Solicitante:

SAMSUNG ELECTRONICS CO LTD [KR]

EP_3708080_A1

Resumen de: US2020293882A1

A recurrent neural network that predicts blood glucose level includes a first long short-term memory (LSTM) network and a second LSTM network. The first LSTM network may include an input to receive near-infrared (NIR) radiation data and includes an output. The second LSTM network may include an input to receive the output of the first LSTM network and an output to output blood glucose level data based on the NIR radiation data input to the first LSTM network.

traducir

NEAR-INFRARED SPECTROSCOPY (NIR) BASED GLUCOSE PREDICTION USING DEEP LEARNING

NºPublicación: EP3708080A1 16/09/2020

Solicitante:

SAMSUNG ELECTRONICS CO LTD [KR]

Resumen de: EP3708080A1

Provided is a recurrent neural network that predicts blood glucose level. The RNN includes a first long short-term memory (LSTM) network and a second LSTM network. The first LSTM network may include an input to receive near-infrared (NIR) radiation data and includes an output. The second LSTM network may include an input to receive the output of the first LSTM network and an output to output blood glucose level data based on the NIR radiation data input to the first LSTM network.

traducir

APPARATUS AND METHOD FOR MEASURING BIO-INFORMATION

NºPublicación: EP3708070A1 16/09/2020

Solicitante:

SAMSUNG ELECTRONICS CO LTD [KR]

Resumen de: EP3708070A1

An apparatus for measuring bio-information may include a pulse wave sensor comprising at least one pair of light emitters which are disposed apart from each other and a light receiver disposed between the at least one pair of light emitters, the pulse wave sensor being configured to measure a plurality of pulse wave signals, in particular photoplethysmogram, PPG, signals, from an object by using the light receiver and the at least one pair of light emitters, in particular wherein the bio-information comprises at least one of blood pressure, blood glucose, cholesterol, vascular age, arterial stiffness, aortic pressure waveform, vascular compliance, blood triglyceride, cardiac output, total peripheral resistance, stress index, and degree of fatigue, a processor, and a force sensor configured to measure a contact force that is applied to the pulse wave sensor by the object, or a force distribution sensor configured to measure a contact force distribution of a contact force that is applied to a contact surface of the pulse wave sensor by the object and is distributed along the contact surface of the pulse wave sensor; wherein, if the apparatus comprises the force sensor, the processor is configured to generate an integrated pulse wave signal by integrating the plurality of pulse wave signals based on the contact force and an area of a contact surface of the pulse wave sensor, and estimate bio-information of the object based on the integrated pulse wave signal, or wherein, if the

traducir

CLOSED-LOOP BLOOD GLUCOSE CONTROL SYSTEMS AND METHODS

NºPublicación: US2020282141A1 10/09/2020

Solicitante:

DIABELOOP [FR]

KR_20200037233_A

Resumen de: US2020282141A1

An automated closed-loop blood glucose control system comprises a continuous glucose-monitoring sensor (101), a subcutaneous insulin delivery device (103); and a controller (105) which determines a maximal allowable insulin injection amount and determines an insulin delivery control signal on the basis of the maximal allowable insulin injection amount and the quantity of insulin to inject.

traducir

LOW ENERGY COMMUNICATOR BETWEEN EXTERNAL PROGRAMMER AND IMPLANTABLE MEDICAL DEVICES USING BLE TECHNOLOGY

NºPublicación: AU2020101619A4 10/09/2020

Solicitante:

AHMED MOHAMMED AZAHAR MR [IN]
GARG LALIT DR [MT]
GUPTA RAHUL DEV DR [IN]
KALRA GOURAV MR [IN]
N S SURESH DR [IN]
PATAN MUZEEB KHAN MR [IN]
REDDY JONNALA SUBBA MR [IN]
T ANIL KUMAR DR [IN]
V RAMAKRISHNA DR [IN]
KUNA PRASHANT MR [IN]

Resumen de: AU2020101619A4

LOW ENERGY COMMUNICATOR BETWEEN EXTERNAL PROGRAMMER AND IMPLANTABLE MEDICAL DEVICES USING BLE TECHNOLOGY Healthcare technology is an integral part of the diagnosis and the treatment, as there is a rapid growth in the medical devices and the sensors. Online telemedical services to individuals are very much useful due to possible flexibility and effective healthcare services. This type of service is developed because of the advanced technologies in wearable sensors and wireless communication. The medical costs get reduced due to the electronic wireless sensor and has capability of enabling the physicians to monitor the signs like blood pressure, the glucose level in the blood, and blood oxygenation of the patient while they remain at home. Implantable medical devices (IMDs) are used to monitor the patient's condition continuously. In case, if any of the emergencies is necessary, the treatment can be applied to the patient. IMDs will be useful only for the patients who visit the hospitals regularly. The Bluetooth low energy is used to link the wireless sensors through the radio signals of the mobile phones and computers, which will be fitted for the next generation of Bluetooth wireless technology. Bluetooth Low Energy is used as the communication method in the medical devices and the sensors. The BLE offers power efficiency, and the transmission data rate is moderate. 1 P a g e LOW ENERGY COMMUNICATOR BETWEEN EXTERNAL PROGRAMMER AND IMPLANTABLE MEDICAL DEVICES USING BLE TECHNOL

traducir

BLOOD SUGAR LEVEL MEASUREMENT DEVICE, BLOOD SUGAR LEVEL MEASUREMENT METHOD, AND PROBE

NºPublicación: WO2020179664A1 10/09/2020

Solicitante:

UNIV TOKYO [JP]

Resumen de: WO2020179664A1

Provided is a blood sugar level measurement device 100 that measures blood sugar levels from measurement signals from a 3-port probe comprising a transmission port, detection port, and reference port for a waveguide that transmits electromagnetic waves. A detection port signal input unit 20 obtains detection port signals from the probe. A reference port signal input unit 30 obtains reference port signals from the probe. A correction unit 40 generates a corrected signal that has a reference port signal subtracted from a detection port signal. A complex neural network 60: uses a pair comprising a corrected signal and a glucose concentration as teacher data and learns weighting; and estimates glucose concentration as output data, by using the generated corrected signal as input data and calculating an output using a non-linear activation function for a weighted sum, in each layer. Provided is a probe comprising: a transmission port and detection port for a waveguide for electromagnetic waves; and a section that sandwiches the skin of a person, in a path from the transmission port in the waveguide and the detection port. A dielectric material is filled inside the waveguide.

traducir

Bolus Calculator and Method for Calculating a Bolus

NºPublicación: US2020282142A1 10/09/2020

Solicitante:

SANOFI SA [FR]

CN_111226284_A

Resumen de: US2020282142A1

The present disclosure relates to a bolus calculator for determining a bolus of insulin, the bolus calculator having an input configured to be fed with a time series (h(t-t)) of blood glucose values and to store at least one known pulse response (x(T)) representing an active profile of at least one insulin, wherein the bolus calculator is configured to convolute the time series (h(t-T)) of blood glucose values with the known pulse response (x(T)) to obtain the bolus and to a method for calculating a bolus of insulin, comprising feeding a time series (h(t-T)) of blood glucose values into an input of a bolus calculator and storing at least one known pulse response (x(T)) representing an active profile of at least one insulin in the bolus calculator, convoluting the time series (h(t-T)) of blood glucose values with the known pulse response (x(T)) to obtain the bolus.

traducir

SYSTEMS AND METHODS FOR DYNAMICALLY AND INTELLIGENTLY MONITORING A HOST'S GLYCEMIC CONDITION AFTER AN ALERT IS TRIGGERED

NºPublicación: US2020281541A1 10/09/2020

Solicitante:

DEXCOM INC [US]

US_2020138385_A1

Resumen de: US2020281541A1

Systems and methods for providing sensitive and specific alarms indicative of glycemic condition are provided herein. In an embodiment, a method of processing sensor data by a continuous analyte sensor includes: evaluating sensor data using a first function to determine whether a real time glucose value meets a first threshold; evaluating sensor data using a second function to determine whether a predicted glucose value meets a second threshold; activating a hypoglycemic indicator if either the first threshold is met or if the second threshold is predicted to be met; and providing an output based on the activated hypoglycemic indicator.

traducir

TRAIN-LIKE PHARMACEUTICAL CONFIGURATION, APPARATUS FOR PREPARATION AND STORAGE DEVICE THEREOF

NºPublicación: US2020281551A1 10/09/2020

Solicitante:

DONG YONGHUA [US]
DONG RUI [US]
MEDESSENCE LIFESCIENCES SUZHOU INC [CN]

JP_2020515592_A

Resumen de: US2020281551A1

The present invention provides a train-like pharmaceutical composition (configuration, or dosage form) comprising segments linearly arranged in series like cars of a train. When the pharmaceutical composition is administrated into a patient's body, some of the segments are “visible” to an instrument, but others are not. However, “invisible” segments can be estimated, deduced, calculated, or inferred from “visible” segments. The “invisible” segments can be used for neutralizing intratumoral lactic acidosis combined with glucose deprivation to control tumor, among other applications.

traducir

IMPLANTABLE SENSOR DEVICES, SYSTEMS, AND METHODS

NºPublicación: US2020281511A1 10/09/2020

Solicitante:

DEXCOM INC [US]

US_2014005509_A1

Resumen de: US2020281511A1

Disclosed herein are devices, systems, and methods for a continuous analyte sensor, such as a continuous glucose sensor. In certain embodiments disclosed herein, various in vivo properties of the sensor's surroundings can be measured. In some embodiments, the measured properties can be used to identify a physiological response or condition in the body. This information can then be used by a patient, doctor, or system to respond appropriately to the identified condition.

traducir

STACKED TISSUE ENCAPSULATION DEVICE SYSTEMS WITH OR WITHOUT OXYGEN DELIVERY

NºPublicación: US2020281709A1 10/09/2020

Solicitante:

UNIV ARIZONA [US]

KR_20190106995_A

Resumen de: US2020281709A1

Systems featuring two or more encapsulation devices stacked together. The encapsulation devices house cells, such as but not limited to islet cells or stem cell derived beta cells or the like. e.g., for regulating blood glucose, or other cells or spheroids that can produce and release a therapeutic agent that is useful in the body, etc. The system may feature oxygen delivery, or in some cases no exogenous oxygen is delivered and vascularization of the device can help provide oxygen and other needed nutrient to the cells. The system of the present invention may be used in conjunction with other therapies such as an artificial pancreas. Stacking the devices with blood vessel formation around and in between them may allow for a decrease in the footprint that would be needed for implantation.

traducir

REMOTE ANALYTE MONITORING AND INSULIN DELIVERY SYSTEM

NºPublicación: EP3704682A1 09/09/2020

Solicitante:

SENSEONICS INCORPORATED [US]

WO_2019089891_A1

Resumen de: US2019125969A1

In one aspect, an analyte monitoring and insulin delivery system is provided. The system may include an analyte sensor configured to convey sensor data indicative of a measurement of one or more detectable properties based on an amount or concentration of an analyte. The system may include a transceiver configured to receive the sensor data and calculate an analyte level based on the sensor data. The system may include a display device configured to receive calculate an adjusted insulin delivery rate for an insulin pump and display the received analyte level and/or the adjusted insulin delivery rate. The system may include the insulin pump configured to increase, decrease or maintain a first insulin delivery rate based on the adjusted insulin delivery rate. The display device may further display icons corresponding to the system components and an operational status indicator for each icon.

traducir

DIABETES MANAGEMENT PARTNER INTERFACE FOR WIRELESS COMMUNICATION OF ANALYTE DATA

NºPublicación: EP3704912A1 09/09/2020

Solicitante:

DEXCOM INC [US]

CN_111247853_A

Resumen de: US2019132801A1

Systems, devices, and methods are disclosed for wireless communication of analyte data. In embodiments, a method of using a diabetes management partner interface to configure an analyte sensor system for wireless communication with a plurality of partner devices is provided. The method includes the analyte sensor system receiving authorization to provide one of the partner devices with access to a set of configuration parameters via the diabetes management partner interface. The set of configuration parameters is stored in a memory of the analyte sensor system. The method also includes, responsive to input received from the one partner device via the diabetes management partner interface, the analyte sensor system setting or causing a modification to the set of configuration parameters, according to a system requirement of the one partner device.

traducir

ELECTRONIC DEVICE AND CONTROL METHOD THEREFOR

NºPublicación: US2020275865A1 03/09/2020

Solicitante:

SAMSUNG ELECTRONICS CO LTD [KR]

KR_20180106783_A

Resumen de: US2020275865A1

An electronic device and a control method therefor are disclosed. The electronic device control method according to the present invention comprises the steps of: receiving blood glucose information and skin temperature information from a blood glucose meter; obtaining external temperature information of a region in which a user wearing the blood glucose meter is located; determining, by using the skin temperature information and the external temperature information, the predictive temperature of an inner skin part at which an enzyme sensor of the blood glucose meter is located; correcting the blood glucose information on the basis of the determined predictive temperature; and outputting the corrected blood glucose information. Therefore, even if the skin temperature rapidly rises or falls because of the external temperature, the electronic device can provide a result similar to the blood glucose value, measured by a disposable blood glucose meter, by correcting a blood glucose value in consideration of the temperature in the skin into which the sensor of a blood glucose meter for measuring blood glucose is inserted.

traducir

GLUCOSE TEST ARRANGEMENT AND METHOD

NºPublicación: US2020275868A1 03/09/2020

Solicitante:

ROCHE DIABETES CARE INC [US]

JP_2020524800_A

Resumen de: US2020275868A1

A glucose test arrangement is provided for use in a handheld meter. The arrangement comprises a disposable test pad responsive to glucose in a body fluid, and a supporting member adapted to support the test pad at an application site for applying body fluid from a user's skin onto a receiving area of the test pad. The receiving area faces away from the supporting member. One or more spacer elements are arranged on the supporting member adjacent to the test pad, wherein the one or more spacer elements have a skin-contacting end section which protrudes above the receiving area.

traducir

Implantable Glucose Monitor

NºPublicación: US2020275867A1 03/09/2020

Solicitante:

SANOFI SA [FR]

WO_2019101612_PA

Resumen de: US2020275867A1

Implantable device for measuring the glucose concentration of a body fluid when implanted, the implantable device comprising a glucose measurement unit, the glucose measurement unit comprising a first light source configured to emit light towards a light transmissive part of a housing of the device and a first optical sensor configured to detect light returned through the light transmissive part from the first light source, and output a first electrical signal based on the detected light; and a wireless communication module configured to wirelessly communicate with an external wireless communication device, wherein the wireless communication module is configured to wirelessly transmit a signal based on the first electrical signal to the external wireless communication device.

traducir

SYSTEMS, DEVICES, AND METHODS FOR ALLEVIATING GLUCOTOXICITY AND RESTORING PANCREATIC BETA-CELL FUNCTION IN ADVANCED DIABETES MELLITUS

NºPublicación: US2020275884A1 03/09/2020

Solicitante:

HYGIEIA INC [US]

US_2014343530_PA

Resumen de: US2020275884A1

Systems, methods and/or devices for treating diabetes mellitus by alleviating glucotoxicity and restoring pancreatic beta-cell function, comprising at least a first memory for storing data inputs corresponding at least to one or more components in a patient's present insulin dosage regimen, and data inputs corresponding at least to the patient's blood-glucose-level measurements determined at a plurality of times, and a processor operatively connected to the at least first memory. The processor is programmed at least to determine from the data inputs corresponding to the patient's blood-glucose-level measurements determined at a plurality of times whether and by how much to vary at least one of the components of the patient's present insulin dosage regimen. Also disclosed are systems, methods, and/or devices for alleviating glucotoxicity and restoring pancreatic beta-cell function, comprising establishing the patient's current glycemic state relative to a desired glycemic range and determining from at least one of a plurality of the data corresponding to the patient's blood glucose-level measurements whether and by how much to adjust at least one of the components in the patient's present insulin dosage regimen.

traducir

SYSTEM AND METHOD FOR ELECTRICAL NERVE AND MUSCLE STIMULATION

NºPublicación: WO2020176050A1 03/09/2020

Solicitante:

SANOTECH TEKNOLOJI SANAYI TICARET LTD SIRKETI [TR]

Resumen de: WO2020176050A1

The invention concerns a wireless, wearable electrical nerve and muscle stimulation system and method designed for the purpose of alleviating the abnormal foot sensations such as burning, stinging and pain experienced especially by diabetes patients.

traducir

Devices, methods, and systems for the treatment and/or monitoring of damaged tissue

NºPublicación: AU2019217431A1 03/09/2020

Solicitante:

ADLORE INC

WO_2019156951_A1

Resumen de: AU2019217431A1

Disclosed are methods, devices, and systems for treatment of an abnormal wound healing response. The methods, devices, and systems can be used to treat solid ulcerated tissue, such as diabetic foot ulcers (DFUs), arthritic tissue, muscle soreness, joint pain, varicose veins, obesity, and peripheral artery disease. Additionally, the methods, devices, and systems can promote the healing of xenograft, allograft, autograft, or engineered tissue following reconstruction surgery. The methods, devices, and systems include the ability to determine an optimal set of pulse parameters that are specific to wound healing. In embodiments, the methods, devices, and systems include components for guiding the user on electrode placement based on anatomical or electrical measurements, delivering a custom series of electric pulses, applying heat, and using feedback from physiologic measurements to control the device.

traducir

METHOD, SYSTEM AND COMPUTER PROGRAM PRODUCT FOR CGM-BASED PREVENTION OF HYPOGLYCEMIA VIA HYPOGLYCEMIA RISK ASSESSMENT AND SMOOTH REDUCTION INSULIN DELIVERY

Nº publicación: EP3703066A1 02/09/2020

Solicitante:

THE UNIV OF VIRGINIA PATENT FOUNDATION [US]

US_2017337348_A1

Resumen de: EP3703066A1

An aspect of an embodiment or partial embodiment of the present invention (or combinations of various embodiments in whole or in part of the present invention) comprises, but not limited thereto, a method and system (and related computer program product) for continually assessing the risk of hypoglycemia for a patient and then determining what action to take based on that risk assessment. A further embodiment results in two outputs: (1) an attenuation factor to be applied to the insulin rate command sent to the pump (either via conventional therapy or via open or closed loop control) and/or (2) a red/yellow/green light hypoglycemia alarm providing to the patient an indication of the risk of hypoglycemia. The two outputs of the CPHS can be used in combination or individually.

traducir

Página1 de 5 nextPage por página

punteroimgVolver